Click here to close now.




















Welcome!

News Feed Item

Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312346/Traumatic-Spinal-Cord-Injury-Global-Clinical-Trials-Review-H2-2014.html

Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014" provides data on the Traumatic Spinal Cord Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Traumatic Spinal Cord Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Traumatic Spinal Cord Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6

Traumatic Spinal Cord Injury 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Traumatic Spinal Cord Injury 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Traumatic Spinal Cord Injury Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Stem Cell Sciences UK Ltd 28

Clinical Trial Overview of Stem Cell Sciences UK Ltd 28
NuVasive, Inc. 29
Clinical Trial Overview of NuVasive, Inc. 29
AOSpine International 30
Clinical Trial Overview of AOSpine International 30
Acorda Therapeutics, Inc. 31
Clinical Trial Overview of Acorda Therapeutics, Inc. 31
Clinical Trial Overview of Top Institutes / Government 32
Simon Fraser University 32
Clinical Trial Overview of Simon Fraser University 32
Tehran University of Medical Sciences 33
Clinical Trial Overview of Tehran University of Medical Sciences 33
Shanghai Changzheng Hospital 34
Clinical Trial Overview of Shanghai Changzheng Hospital 34
Christian Medical College 35
Clinical Trial Overview of Christian Medical College 35
Indian Council of Medical Research 36
Clinical Trial Overview of Indian Council of Medical Research 36
Rennes University Hospital 37
Clinical Trial Overview of Rennes University Hospital 37
Yonsei University 38
Clinical Trial Overview of Yonsei University 38
Capital District Health Authority, Canada 39
Clinical Trial Overview of Capital District Health Authority, Canada 39
Hadassah Medical Organization 40
Clinical Trial Overview of Hadassah Medical Organization 40
University of Miami 41
Clinical Trial Overview of University of Miami 41
Five Key Clinical Profiles 42
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

List of Tables
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region, 2014* 7
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Traumatic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Traumatic Spinal Cord Injury Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Traumatic Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26

Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Stem Cell Sciences UK Ltd, 2014* 28
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by NuVasive, Inc., 2014* 29
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by AOSpine International, 2014* 30
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014* 31
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Simon Fraser University, 2014* 32
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 33
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Changzheng Hospital, 2014* 34
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Christian Medical College, 2014* 35
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Indian Council of Medical Research, 2014* 36
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Rennes University Hospital, 2014* 37
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 38
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2014* 39
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 40
Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014* 41

List of Figures
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Traumatic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Traumatic Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 57

Read the full report:
Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312346/Traumatic-Spinal-Cord-Injury-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Micron Technology, Inc., a global leader in advanced semiconductor systems, will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Micron’s broad portfolio of high-performance memory technologies – including DRAM, NAND and NOR Flash – is the basis for solid state drives, modules, multichip packages and other system solutions. Backed by more than 35 years of tech...
Through WebRTC, audio and video communications are being embedded more easily than ever into applications, helping carriers, enterprises and independent software vendors deliver greater functionality to their end users. With today’s business world increasingly focused on outcomes, users’ growing calls for ease of use, and businesses craving smarter, tighter integration, what’s the next step in delivering a richer, more immersive experience? That richer, more fully integrated experience comes ab...
Everyone talks about continuous integration and continuous delivery but those are just two ends of the pipeline. In the middle of DevOps is continuous testing (CT), and many organizations are struggling to implement continuous testing effectively. After all, without continuous testing there is no delivery. And Lab-As-A-Service (LaaS) enhances the CT with dynamic on-demand self-serve test topologies. CT together with LAAS make a powerful combination that perfectly serves complex software developm...
As more intelligent IoT applications shift into gear, they’re merging into the ever-increasing traffic flow of the Internet. It won’t be long before we experience bottlenecks, as IoT traffic peaks during rush hours. Organizations that are unprepared will find themselves by the side of the road unable to cross back into the fast lane. As billions of new devices begin to communicate and exchange data – will your infrastructure be scalable enough to handle this new interconnected world?
In today's digital world, change is the one constant. Disruptive innovations like cloud, mobility, social media, and the Internet of Things have reshaped the market and set new standards in customer expectations. To remain competitive, businesses must tap the potential of emerging technologies and markets through the rapid release of new products and services. However, the rigid and siloed structures of traditional IT platforms and processes are slowing them down – resulting in lengthy delivery ...
Skeuomorphism usually means retaining existing design cues in something new that doesn’t actually need them. However, the concept of skeuomorphism can be thought of as relating more broadly to applying existing patterns to new technologies that, in fact, cry out for new approaches. In his session at DevOps Summit, Gordon Haff, Senior Cloud Strategy Marketing and Evangelism Manager at Red Hat, discussed why containers should be paired with new architectural practices such as microservices rathe...
U.S. companies are desperately trying to recruit and hire skilled software engineers and developers, but there is simply not enough quality talent to go around. Tiempo Development is a nearshore software development company. Our headquarters are in AZ, but we are a pioneer and leader in outsourcing to Mexico, based on our three software development centers there. We have a proven process and we are experts at providing our customers with powerful solutions. We transform ideas into reality.
Any Ops team trying to support a company in today’s cloud-connected world knows that a new way of thinking is required – one just as dramatic than the shift from Ops to DevOps. The diversity of modern operations requires teams to focus their impact on breadth vs. depth. In his session at DevOps Summit, Adam Serediuk, Director of Operations at xMatters, Inc., will discuss the strategic requirements of evolving from Ops to DevOps, and why modern Operations has begun leveraging the “NoOps” approa...
Organizations from small to large are increasingly adopting cloud solutions to deliver essential business services at a much lower cost. According to cyber security experts, the frequency and severity of cyber-attacks are on the rise, causing alarm to businesses and customers across a variety of industries. To defend against exploits like these, a company must adopt a comprehensive security defense strategy that is designed for their business. In 2015, organizations such as United Airlines, Sony...
Puppet Labs has announced the next major update to its flagship product: Puppet Enterprise 2015.2. This release includes new features providing DevOps teams with clarity, simplicity and additional management capabilities, including an all-new user interface, an interactive graph for visualizing infrastructure code, a new unified agent and broader infrastructure support.
WebRTC has had a real tough three or four years, and so have those working with it. Only a few short years ago, the development world were excited about WebRTC and proclaiming how awesome it was. You might have played with the technology a couple of years ago, only to find the extra infrastructure requirements were painful to implement and poorly documented. This probably left a bitter taste in your mouth, especially when things went wrong.
SYS-CON Events announced today that HPM Networks will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. For 20 years, HPM Networks has been integrating technology solutions that solve complex business challenges. HPM Networks has designed solutions for both SMB and enterprise customers throughout the San Francisco Bay Area.
Red Hat is investing in Tesora, the number one contributor to OpenStack Trove Database as a Service (DBaaS) also ranked among the top 20 companies contributing to OpenStack overall. Tesora, the company bringing OpenStack Trove Database as a Service (DBaaS) to the enterprise, has announced that Red Hat and others have invested in the company as a part of Tesora's latest funding round. The funding agreement expands on the ongoing collaboration between Tesora and Red Hat, which dates back to Febr...
As more and more data is generated from a variety of connected devices, the need to get insights from this data and predict future behavior and trends is increasingly essential for businesses. Real-time stream processing is needed in a variety of different industries such as Manufacturing, Oil and Gas, Automobile, Finance, Online Retail, Smart Grids, and Healthcare. Azure Stream Analytics is a fully managed distributed stream computation service that provides low latency, scalable processing of ...
Too often with compelling new technologies market participants become overly enamored with that attractiveness of the technology and neglect underlying business drivers. This tendency, what some call the “newest shiny object syndrome,” is understandable given that virtually all of us are heavily engaged in technology. But it is also mistaken. Without concrete business cases driving its deployment, IoT, like many other technologies before it, will fade into obscurity.